Clinical Trials Detail

Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

A Pragmatic trial to Improve Colony Stimulating Factor for Use in Cancer

Objective
CategoryInformation
Study #: EAQ152 - COMET
Anatomic Site:
  • Metastatic
  • Non-metastatic
  • Non-Small Cell Lung Cancer (NSCLC)
  • Non-Small Cell Lung Carcinoma
Histology:
  • Advanced Malignant Neoplasm
  • Locally Advanced Malignant Neoplasm
Mutation:
  • Breast: Stage 0, Stage IA, Stage IB, Stage IIA, Stage IIB, Stage IIIA, Stage IIIB, Stage IIIC, Stage IV
  • Colorectal: Stage 0, Stage I, Stage IIA, Stage IIB, Stage IIC, Stage IIIA, Stage IIIB, Stage IIIC, Stage IVA, Stage IVB
  • NSCLC: Stage 0, Stage IIA, Stage IIB, Stage IV
  • Carcinoma: Stage IA, Stage IB, Stage IIA, Stage IIB
Stage: Advanced
Treatment Phase: Patient has current diagnosis. Patient has not had systemic therapy for their diagnosis (or not had systemic therapy for different diagnosis within 180 days).
Location: Baptist Cancer Center - Memphis
Study Link: https://clinicaltrials.gov/ct2/show/NCT02728596?term=S1415CD&rank=1

Clinical Trial Categories

  • Colorectal
  • Lung
  • Breast